BioBos Respi 2 intranasal deguna aerosols, liofilizāts un šķīdinātājs suspensijas pagatavošanai
BioBos Respi 2 intranasal deguna aerosols, liofilizāts un šķīdinātājs suspensijas pagatavošanai
Authorised
- Bovine respiratory syncytial virus, strain BIO 24/A, Live
- Bovine parainfluenza virus 3, strain BIO 23/A, Live
Product identification
Medicine name:
BioBos Respi 2 intranasal deguna aerosols, liofilizāts un šķīdinātājs suspensijas pagatavošanai
Active substance:
- Bovine respiratory syncytial virus, strain BIO 24/A, Live
- Bovine parainfluenza virus 3, strain BIO 23/A, Live
Target species:
-
Cattle
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Bovine respiratory syncytial virus, strain BIO 24/A, Live7.50/log10 50% tissue culture infectious dose1.00Dose
-
Bovine parainfluenza virus 3, strain BIO 23/A, Live6.00/log10 50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Nasal spray, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
-
Nasal use
-
Cattle
-
Milk0hour
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/I/25/0035
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
- Vetmarket UAB
Destination wholesaler:
- Vetmarket SIA
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet